Adaptin Bio (APTN) Non-Current Debt (2022 - 2024)

Adaptin Bio (APTN) has 3 years of Non-Current Debt data on file, last reported at $31000.0 in Q3 2024.

• For the quarter ending Q3 2024, Non-Current Debt rose 63.16% year-over-year to $31000.0; the trailing twelve-month figure through Sep 2024 stood at $31000.0 (up 63.16% YoY), and the FY2023 full-year result was $10000.0, up 100.0% from the prior year.
• Non-Current Debt climbed to $31000.0 in Q3 2024, from $28000.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $81219.0 in Q1 2024 to a low of $5000.0 in Q4 2022.
• A 3-year average of $29036.5 and a median of $23500.0 in 2023 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt surged 100.0% in 2023 and soared 63.16% in 2024, its largest moves.
• Tracing APTN's Non-Current Debt over 3 years: stood at $5000.0 in 2022, then surged by 100.0% to $10000.0 in 2023, then soared by 210.0% to $31000.0 in 2024.
• Business Quant data shows APTN's Non-Current Debt at $31000.0 in Q3 2024, $28000.0 in Q2 2024, and $81219.0 in Q1 2024.